The Planning Commission is back in the news. The latest round of poverty levels that have been disclosed have created another debate in the country. Once more, people are stunned at the meager rate of Rs 28 that has been defined as the poverty line. Even though I addressed some apprehensions in an earlier post, this time around the issue seems to be more about myths, perceptions and lack of...

-PTI The UIDAI's Aadhaar project for providing unique identity numbers to residents, has huge potential to improve the delivery of social sector schemes like rural employment guarantee, the Economic Survey 2011-12 said. "Aadhaar has huge potential for improving operations and delivery of services," the survey said. The Unique Identification Authority of India (UIDAI), attached to the Planning Commission, is engaged in providing residents in the country a Unique Identification number (called Aadhaar) linked...

The latest round of data on the 2011 Census shows that the country is exhibiting distinct signs of trading up as material living conditions improve for large sections of the population. Although this aggregate picture is not uniform across the country, analysts believe that the upward material mobility in society is creating the basis of a new consumer boom in the economy—serving up a perfect backdrop ahead of the presentation of...

-DNA Country’s first chief information commissioner (CIC), Wajahat Habibullah, told law and mass communication students about the true strength of the Right To Information (RTI) Act, 2005. He said RTI Act is not a weapon to be used against the government but to strengthen the system, exposing the weaknesses within its functioning. He was speaking at a daylong workshop on ‘RTI and media—Partners for priority’ organised by Symbiosis Institute of Media and...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...